Allergan, Inc. (Public, NYSE:AGN) Allergan profit falls in 3Q, plans to buy French company Los Angeles Business from bizjournals - November 1, 2006 Print this Article Email this Article Reprints RSS Feeds Most Viewed Most Emailed Allergan Inc.'s third quarter profit was down because of charges due to its March buyout of Inamed, and it announced plans to buy Paris' Groupe Corneal Laboratoires for $216 million, the company said Wednesday.
Revenue was $806.8 million, up 32 percent from $611.4 million in the year-ago period. More: http://www.bizjournals.com/losangeles/stories/2006/10/30/daily36.html http://tech.groups.yahoo.com/group/biotech-news/ http://www.arizonabiotech.com/ http://www.azhttp.com/ http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> Your email settings: Individual Email | Traditional <*> To change settings online go to: http://groups.yahoo.com/group/biotech-news/join (Yahoo! ID required) <*> To change settings via email: mailto:[EMAIL PROTECTED] mailto:[EMAIL PROTECTED] <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
